They’ve marshalled forces and pushed back on legislative efforts to curb exemptions, although three states have managed to do so.
Insurers say opening up clinics in drugstores will make health care more convenient, more timely—and potentially less costly. But will it also bring unwanted commercialization and fragmentation?
You can’t know everything, and neither can your staff. Bringing in outside expertise can be a godsend for health systems, health plans, pharma manufacturers, or governments—if they use it properly. Trouble is, that’s a big “if.”
Steve Miller, MD, now at Cigna, and Alan Adler, MD, recently retired from Independence Blue Cross in Philadelphia, reflect on their roles as medical directors and the current state of American health care.
The TNF inhibitors have ruled the roost, and Humira is the top selling drug in the world. But the interleukin inhibitors are challenging TNF inhibitor hegemony.
Instead of retrofitting for the new world of “value,” what would it be like if a brand-new medical school and health system were built with that mindset from the start? Clay Johnston, MD, and his colleagues in Austin are finding out.
The gender imbalance in health care leadership is a problem worth solving, experts say. That will require women willing to step forward—and men willing to back them.
A new report finds that successful programs have a third dimension beyond financial incentives and quality measurement.
